4//SEC Filing
Wissel Janne LT 4
Accession 0001232524-10-000033
CIK 0001232524other
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 6:52 PM ET
Size
6.9 KB
Accession
0001232524-10-000033
Insider Transaction Report
Form 4
Wissel Janne LT
SVP, Chief Regulatory Officer
Transactions
- Sale
Common Stock
2010-12-07$18.75/sh−500$9,375→ 106,721 total - Sale
Common Stock
2010-12-08$18.38/sh−59,500$1,093,610→ 47,221 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.36 to $18.41, inclusive.
- [F2]The reporting person undertakes to provide to Jazz Pharmaceuticals, Inc., any security holder of Jazz Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (1) to this Form 4.
Documents
Issuer
JAZZ PHARMACEUTICALS INC
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001397268
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 6:52 PM ET
- Size
- 6.9 KB